NCT01084148View on ClinicalTrials.gov

Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

March 31, 2009

Conditions
Uremic Xerosis
Interventions
DRUG

V0034CR01B

DRUG

V0034CR01B vehicle

Sponsors

Lead Sponsor

Orfagen
All Listed Sponsors
lead

Orfagen

INDUSTRY